DocGo Inc. (NASDAQ:DCGO) Receives $6.10 Consensus Price Target from Brokerages

DocGo Inc. (NASDAQ:DCGO) has earned a consensus rating of “Buy” from the five research firms that are presently covering the company, MarketBeat.com reports. Five research analysts have rated the stock with a buy recommendation. The average 12-month price objective among brokerages that have updated their coverage on the stock in the last year is $6.10.

A number of analysts have weighed in on DCGO shares. Cantor Fitzgerald reissued an “overweight” rating and set a $5.00 price objective on shares of DocGo in a report on Tuesday, August 20th. Stifel Nicolaus dropped their price objective on DocGo from $8.00 to $6.50 and set a “buy” rating on the stock in a report on Tuesday, April 30th. Canaccord Genuity Group reduced their target price on DocGo from $9.00 to $5.00 and set a “buy” rating for the company in a report on Thursday, May 9th. BTIG Research dropped their price target on DocGo from $11.00 to $7.00 and set a “buy” rating on the stock in a research note on Thursday, May 9th. Finally, Needham & Company LLC reiterated a “buy” rating and issued a $7.00 price objective on shares of DocGo in a research note on Thursday, August 8th.

DocGo Trading Up 7.5 %

DocGo stock opened at $3.72 on Thursday. The company has a fifty day simple moving average of $3.25 and a 200-day simple moving average of $3.42. The stock has a market cap of $377.83 million, a P/E ratio of 18.60, a price-to-earnings-growth ratio of 1.74 and a beta of 0.91. DocGo has a 12-month low of $2.75 and a 12-month high of $9.11.

Institutional Trading of DocGo

Several hedge funds and other institutional investors have recently made changes to their positions in the stock. Harbor Capital Advisors Inc. raised its holdings in DocGo by 273.4% during the second quarter. Harbor Capital Advisors Inc. now owns 396,015 shares of the company’s stock worth $1,224,000 after purchasing an additional 289,964 shares during the last quarter. Jacobs Levy Equity Management Inc. purchased a new stake in shares of DocGo in the 1st quarter worth about $672,000. Birchview Capital LP boosted its position in shares of DocGo by 15.4% in the 4th quarter. Birchview Capital LP now owns 150,000 shares of the company’s stock worth $838,000 after buying an additional 20,000 shares in the last quarter. S Squared Technology LLC grew its stake in DocGo by 36.7% in the 4th quarter. S Squared Technology LLC now owns 1,024,438 shares of the company’s stock valued at $5,727,000 after acquiring an additional 275,000 shares during the last quarter. Finally, Pasadena Private Wealth LLC increased its holdings in DocGo by 363.6% during the 1st quarter. Pasadena Private Wealth LLC now owns 395,487 shares of the company’s stock valued at $1,598,000 after acquiring an additional 310,180 shares in the last quarter. Institutional investors and hedge funds own 56.44% of the company’s stock.

DocGo Company Profile

DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.